AirMed and PathSensors are working together to offer an innovative and cost-effective solution for pathogen detection and treatment with unparalleled control and precision to drive higher revenue. CANARY (Cellular Analysis and Notification of Antigen Risks and Yields) is a cell-based biosensor technology that delivers extremely rapid detection of pathogens at previously unseen levels of sensitivity and specificity. Originally developed by scientists at MIT Lincoln Laboratories to combat bioterrorism threats, the CANARY technology has been adapted by PathSensors for applications in agriculture and food safety.
PathSensors’ BioFlash® Biological Identifier is highly-portable and incorporates a high-volume, high-performance aerosol sampler for indoor/outdoor applications. Incorporating the CANARY® technology, the BioFlash® Biological Identifier provides rapid, sensitive and specific identification of biological threat agents and other pathogens including toxins.
The Zephyr Pathogen Identifier uses CANARY® detection technology to screen for pathogens in liquid and powder samples. The Zephyr platform is ideal for users who need rapid, accurate results, and who test lower volumes of samples (<40 tests/day).
For more information about the AirMed Ecosystem and all our partners visit our partner page: AirMed Ecosystem